ZIOP Historical PE Ratio image   This ZIOP PE ratio history page last updated 11/10/2021
ZIOP PE History Chart
PeriodPriceGAAPTTMPE
Q3 2021
11/8/2021
1.63-0.11-0.43NA
Q2 2021
8/9/2021
2.29-0.11-0.42NA
Q1 2021
5/6/2021
2.99-0.10-0.40NA
Q4 2020
2/25/2021
4.65-0.11-0.39NA
Q3 2020
11/5/2020
2.42-0.10-0.37NA
Q2 2020
8/6/2020
3.20-0.09-0.35NA
Q1 2020
5/7/2020
2.65-0.09-0.35NA
Q4 2019
3/2/2020
3.14-0.09-0.34NA
Q3 2019
11/7/2019
4.28-0.08-0.33NA
Q2 2019
8/8/2019
5.68-0.09-0.38NA
Q1 2019
5/8/2019
4.41-0.08-0.41NA
Q4 2018
3/5/2019
2.95-0.08-0.48NA
Q3 2018
11/9/2018
2.51-0.13-0.53NA
Q2 2018
8/8/2018
2.51-0.12-0.53NA
Q1 2018
5/10/2018
4.51-0.15-0.54NA
Q4 2017
3/1/2018
3.62-0.13-0.54NA
Q3 2017
11/6/2017
4.67-0.13-0.52NA
Q2 2017
7/31/2017
5.53-0.13-0.50NA
Q1 2017
5/1/2017
7.10-0.15-0.47NA
Q4 2016
2/16/2017
6.81-0.11-0.41NA
Q3 2016
11/9/2016
6.24-0.11-0.37NA
Q2 2016
8/9/2016
4.86-0.10-0.40NA
Q1 2016
5/10/2016
7.48-0.09-0.41NA
Q4 2015
2/24/2016
7.96-0.07-0.42NA
Q3 2015
11/2/2015
12.25-0.14-0.44NA
Q2 2015
8/10/2015
11.92-0.11-0.36NA
Q1 2015
5/7/2015
10.50-0.10-0.31NA
Q4 2014
2/26/2015
11.78-0.09-0.31NA
Q3 2014
10/30/2014
3.06-0.06-0.31NA
Q2 2014
8/7/2014
3.09-0.06-0.45NA
Q1 2014
5/8/2014
2.96-0.10-0.61NA
Q4 2013
3/3/2014
4.21-0.09-0.79NA
Q3 2013
10/22/2013
4.93-0.20-1.18NA
Q2 2013
8/8/2013
3.08-0.22-1.19NA
Q1 2013
5/7/2013
1.70-0.28-1.16NA
Q4 2012
3/18/2013
5.71-0.48NANA
Q3 2012
11/8/2012
4.53-0.21NANA
Q2 2012
8/2/2012
5.59-0.19NANA
ZIOP Historical PE Ratio Chart
Data adjusted for ZIOP split history

PeriodPriceGAAPAnnualizedPE
Q3 2021
11/8/2021
1.63-0.11-0.44NA
Q2 2021
8/9/2021
2.29-0.11-0.44NA
Q1 2021
5/6/2021
2.99-0.10-0.40NA
Q4 2020
2/25/2021
4.65-0.11-0.44NA
Q3 2020
11/5/2020
2.42-0.10-0.40NA
Q2 2020
8/6/2020
3.20-0.09-0.36NA
Q1 2020
5/7/2020
2.65-0.09-0.36NA
Q4 2019
3/2/2020
3.14-0.09-0.36NA
Q3 2019
11/7/2019
4.28-0.08-0.32NA
Q2 2019
8/8/2019
5.68-0.09-0.36NA
Q1 2019
5/8/2019
4.41-0.08-0.32NA
Q4 2018
3/5/2019
2.95-0.08-0.32NA
Q3 2018
11/9/2018
2.51-0.13-0.52NA
Q2 2018
8/8/2018
2.51-0.12-0.48NA
Q1 2018
5/10/2018
4.51-0.15-0.60NA
Q4 2017
3/1/2018
3.62-0.13-0.52NA
Q3 2017
11/6/2017
4.67-0.13-0.52NA
Q2 2017
7/31/2017
5.53-0.13-0.52NA
Q1 2017
5/1/2017
7.10-0.15-0.60NA
Q4 2016
2/16/2017
6.81-0.11-0.44NA
Q3 2016
11/9/2016
6.24-0.11-0.44NA
Q2 2016
8/9/2016
4.86-0.10-0.40NA
Q1 2016
5/10/2016
7.48-0.09-0.36NA
Q4 2015
2/24/2016
7.96-0.07-0.28NA
Q3 2015
11/2/2015
12.25-0.14-0.56NA
Q2 2015
8/10/2015
11.92-0.11-0.44NA
Q1 2015
5/7/2015
10.50-0.10-0.40NA
Q4 2014
2/26/2015
11.78-0.09-0.36NA
Q3 2014
10/30/2014
3.06-0.06-0.24NA
Q2 2014
8/7/2014
3.09-0.06-0.24NA
Q1 2014
5/8/2014
2.96-0.10-0.40NA
Q4 2013
3/3/2014
4.21-0.09-0.36NA
Q3 2013
10/22/2013
4.93-0.20-0.80NA
Q2 2013
8/8/2013
3.08-0.22-0.88NA
Q1 2013
5/7/2013
1.70-0.28-1.12NA
Q4 2012
3/18/2013
5.71-0.48-1.92NA
Q3 2012
11/8/2012
4.53-0.21-0.84NA
Q2 2012
8/2/2012
5.59-0.19-0.76NA
Quotes delayed 20 minutes

Email EnvelopeFree ZIOP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ZIOPHARM Oncology (ZIOP) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ZNTL PE Ratio History
ZSAN PE Ratio History
ZTS PE Ratio History
ZY PE Ratio History
ZYNE PE Ratio History
ZYXI PE Ratio History
A PE Ratio History
ABBV PE Ratio History
ABC PE Ratio History
ABEO PE Ratio History
On this page we presented the ZIOP PE Ratio History information for ZIOPHARM Oncology' stock. The average ZIOP PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ZIOP PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ZIOP PE ratio history result, against the recent PE: when this page was posted on 11/9/2021, the most recent closing price for ZIOP had been 1.59, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ZIOP or any other given stock, valuation analysis for ZIOP can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate ZIOPHARM Oncology PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for ZIOP. Thanks for visiting, and the next time you need to research ZIOP PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.
 

ZIOP PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.